Neuregulin 4 Downregulation Induces Insulin Resistance in 3T3-L1 Adipocytes through Inflammation and Autophagic Degradation of GLUT4 Vesicles.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
30 Nov 2021
Historique:
received: 28 10 2021
revised: 25 11 2021
accepted: 25 11 2021
entrez: 10 12 2021
pubmed: 11 12 2021
medline: 21 12 2021
Statut: epublish

Résumé

The adipokine Neuregulin 4 (Nrg4) protects against obesity-induced insulin resistance. Here, we analyze how the downregulation of Nrg4 influences insulin action and the underlying mechanisms in adipocytes. Validated shRNA lentiviral vectors were used to generate scramble (Scr) and Nrg4 knockdown (KD) 3T3-L1 adipocytes. Adipogenesis was unaffected in Nrg4 KD adipocytes, but there was a complete impairment of the insulin-induced 2-deoxyglucose uptake, which was likely the result of reduced insulin receptor and Glut4 protein. Downregulation of Nrg4 enhanced the expression of proinflammatory cytokines. Anti-inflammatory agents recovered the insulin receptor, but not Glut4, content. Proteins enriched in Glut4 storage vesicles such as the insulin-responsive aminopeptidase (IRAP) and Syntaxin-6 as well as TBC1D4, a protein involved in the intracellular retention of Glut4 vesicles, also decreased by Nrg4 KD. Insulin failed to reduce autophagy in Nrg4 KD adipocytes, observed by a minor effect on mTOR phosphorylation, at the time that proteins involved in autophagy such as LC3-II, Rab11, and Clathrin were markedly upregulated. The lysosomal activity inhibitor bafilomycin A1 restored Glut4, IRAP, Syntaxin-6, and TBC1D4 content to those found in control adipocytes. Our study reveals that Nrg4 preserves the insulin responsiveness by preventing inflammation and, in turn, benefits the insulin regulation of autophagy.

Identifiants

pubmed: 34884763
pii: ijms222312960
doi: 10.3390/ijms222312960
pmc: PMC8657571
pii:
doi:

Substances chimiques

Cytokines 0
GTPase-Activating Proteins 0
Glucose Transporter Type 4 0
Insulin 0
Neuregulins 0
Qa-SNARE Proteins 0
RNA, Small Interfering 0
Slc2a4 protein, mouse 0
Tbc1d4 protein, mouse 0
neuregulin-4 0
Deoxyglucose 9G2MP84A8W
Receptor, Insulin EC 2.7.10.1
Cystinyl Aminopeptidase EC 3.4.11.3
leucyl-cystinyl aminopeptidase EC 3.4.11.3

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

J Cell Sci. 2004 Jun 1;117(Pt 13):2805-12
pubmed: 15169837
Autophagy. 2010 Aug;6(6):754-63
pubmed: 20574167
Am J Physiol Endocrinol Metab. 2010 Apr;298(4):E742-50
pubmed: 20028964
Nat Commun. 2018 Nov 26;9(1):4974
pubmed: 30478315
J Cell Biochem. 2003 Oct 15;90(3):561-72
pubmed: 14523990
Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12050-5
pubmed: 11593015
Oncogene. 1999 Apr 29;18(17):2681-9
pubmed: 10348342
Essays Biochem. 2017 Dec 12;61(6):565-584
pubmed: 29233869
Am J Physiol Endocrinol Metab. 2014 Apr 15;306(8):E945-64
pubmed: 24549398
Nature. 1995 Nov 23;378(6555):390-4
pubmed: 7477376
Mol Biol Cell. 2003 Jul;14(7):2946-58
pubmed: 12857877
J Biol Chem. 2003 Apr 25;278(17):14599-602
pubmed: 12637568
J Biol Chem. 2003 Nov 14;278(46):45777-84
pubmed: 12952969
Front Physiol. 2019 Jan 31;10:39
pubmed: 30766490
EMBO J. 2018 May 15;37(10):
pubmed: 29632021
Biochem Biophys Res Commun. 2018 Oct 2;504(2):427-433
pubmed: 30195497
Biochem Biophys Res Commun. 2018 Sep 3;503(1):378-384
pubmed: 29902456
EMBO J. 2009 Nov 4;28(21):3290-302
pubmed: 19763082
J Biol Chem. 2012 Nov 16;287(47):39850-8
pubmed: 23033483
J Biol Chem. 2005 Nov 11;280(45):37803-13
pubmed: 16154996
J Biol Chem. 2015 Feb 13;290(7):4447-63
pubmed: 25561724
Nat Cell Biol. 2012 Sep;14(9):924-34
pubmed: 22885770
Cell Death Differ. 2014 Mar;21(3):348-58
pubmed: 24440914
Am J Pathol. 2014 Oct;184(10):2768-78
pubmed: 25216938
Mol Metab. 2017 Jun 21;6(8):863-872
pubmed: 28752050
Nature. 1995 Nov 23;378(6555):394-8
pubmed: 7477377
Am J Physiol Endocrinol Metab. 2018 Oct 1;315(4):E583-E593
pubmed: 29944391
Cell Death Dis. 2017 Feb 23;8(2):e2622
pubmed: 28230865
Diabetes. 2002 Nov;51(11):3176-88
pubmed: 12401708
J Clin Invest. 2017 Dec 1;127(12):4449-4461
pubmed: 29106384
FEBS Lett. 1992 Sep 21;310(1):51-4
pubmed: 1388124
Nature. 1995 Nov 23;378(6555):386-90
pubmed: 7477375
J Biol Chem. 1999 May 28;274(22):15395-400
pubmed: 10336427
J Biol Chem. 2005 Jul 8;280(27):25485-90
pubmed: 15899889
J Biol Chem. 2019 Jul 26;294(30):11369-11381
pubmed: 31175156
Trends Cell Biol. 2015 Sep;25(9):545-55
pubmed: 26159692
PLoS One. 2014 Feb 03;9(2):e87871
pubmed: 24498385
J Cell Biol. 2012 May 28;197(5):659-75
pubmed: 22613832
J Biol Chem. 2001 May 25;276(21):18257-64
pubmed: 11278386
J Biol Chem. 2006 Aug 4;281(31):21690-21697
pubmed: 16740635
J Biol Chem. 1997 Jan 10;272(2):971-6
pubmed: 8995390
Proc Natl Acad Sci U S A. 1994 May 24;91(11):4854-8
pubmed: 8197147
Diabetes. 2015 Mar;64(3):746-59
pubmed: 25249576
Curr Opin Cell Biol. 2010 Aug;22(4):506-12
pubmed: 20417083
Nat Med. 2014 Dec;20(12):1436-1443
pubmed: 25401691
Endocrinology. 2009 Aug;150(8):3493-502
pubmed: 19406948
Autophagy. 2015;11(5):769-84
pubmed: 25945613

Auteurs

Francisco Díaz-Sáez (F)

Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, Av. Diagonal, 643, 08028 Barcelona, Spain.
Institute of Biomedicine, University of Barcelona, 08028 Barcelona, Spain.

Carla Blanco-Sinfreu (C)

Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, Av. Diagonal, 643, 08028 Barcelona, Spain.

Adrià Archilla-Ortega (A)

Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, Av. Diagonal, 643, 08028 Barcelona, Spain.

David Sebastian (D)

Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, Av. Diagonal, 643, 08028 Barcelona, Spain.
Centro de Investigación Biomèdica en Red Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Carlos III Health Institute, 28029 Madrid, Spain.
Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.

Montserrat Romero (M)

Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, Av. Diagonal, 643, 08028 Barcelona, Spain.
Centro de Investigación Biomèdica en Red Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Carlos III Health Institute, 28029 Madrid, Spain.
Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.

Maria Isabel Hernández-Alvarez (MI)

Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, Av. Diagonal, 643, 08028 Barcelona, Spain.
Institute of Biomedicine, University of Barcelona, 08028 Barcelona, Spain.
Centro de Investigación Biomèdica en Red Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Carlos III Health Institute, 28029 Madrid, Spain.

Sílvia Mora (S)

Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, Av. Diagonal, 643, 08028 Barcelona, Spain.
Institute of Biomedicine, University of Barcelona, 08028 Barcelona, Spain.

Xavier Testar (X)

Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, Av. Diagonal, 643, 08028 Barcelona, Spain.
Institute of Biomedicine, University of Barcelona, 08028 Barcelona, Spain.
Centro de Investigación Biomèdica en Red Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Carlos III Health Institute, 28029 Madrid, Spain.

Wifredo Ricart (W)

Department of Medicine, Universitat de Girona, Carrer Emili Grahit, 77, 17071 Girona, Spain.
Department of Diabetes, Endocrinology and Nutrition, Institut d'Investigació Biomèdica de Girona (IDIBGI), Carrer del Dr. Castany, s/n, 17190 Salt, Spain.
Centro de Investigación Biomèdica en Red Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.

José Manuel Fernández-Real (JM)

Department of Medicine, Universitat de Girona, Carrer Emili Grahit, 77, 17071 Girona, Spain.
Department of Diabetes, Endocrinology and Nutrition, Institut d'Investigació Biomèdica de Girona (IDIBGI), Carrer del Dr. Castany, s/n, 17190 Salt, Spain.
Centro de Investigación Biomèdica en Red Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.

José María Moreno-Navarrete (JM)

Department of Medicine, Universitat de Girona, Carrer Emili Grahit, 77, 17071 Girona, Spain.
Department of Diabetes, Endocrinology and Nutrition, Institut d'Investigació Biomèdica de Girona (IDIBGI), Carrer del Dr. Castany, s/n, 17190 Salt, Spain.
Centro de Investigación Biomèdica en Red Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Carlos III Health Institute, 28029 Madrid, Spain.

Julián Aragonés (J)

Research Unit, Hospital of Santa Cristina, Research Institute Princesa, Autonomous University of Madrid, c/Maestro Vives, 2, 28009 Madrid, Spain.
Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares, Carlos III Health Institute, 28029 Madrid, Spain.

Marta Camps (M)

Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, Av. Diagonal, 643, 08028 Barcelona, Spain.
Institute of Biomedicine, University of Barcelona, 08028 Barcelona, Spain.
Centro de Investigación Biomèdica en Red Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Carlos III Health Institute, 28029 Madrid, Spain.

Antonio Zorzano (A)

Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, Av. Diagonal, 643, 08028 Barcelona, Spain.
Centro de Investigación Biomèdica en Red Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Carlos III Health Institute, 28029 Madrid, Spain.
Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.

Anna Gumà (A)

Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, Av. Diagonal, 643, 08028 Barcelona, Spain.
Institute of Biomedicine, University of Barcelona, 08028 Barcelona, Spain.
Centro de Investigación Biomèdica en Red Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Carlos III Health Institute, 28029 Madrid, Spain.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
C-Reactive Protein Humans Biomarkers Inflammation
Humans Immune Checkpoint Inhibitors Lung Neoplasms Prognosis Inflammation

Classifications MeSH